SCHEMBL1163541

SCHEMBL1163541

NC(=O)c1cc(O)ccc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.64
CA1 P00915 5/20 0.64
CA2 P00918 5/20 0.64
CA7 P43166 5/20 0.64
CA9 Q16790 5/20 0.64
CA14 Q9ULX7 5/20 0.64
ALOX5 P09917 1/20 0.64
PTGS2 P35354 1/20 0.64
ALDH1A1 P00352 3/20 0.54
TSHR P16473 2/20 0.54
KDM4E B2RXH2 1/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CHUK O15111 1/20 0.53
CHRNA7 P36544 4/20 0.48
CES2 O00748 1/20 0.48
CLK1 P49759 1/20 0.47
DYRK1A Q13627 1/20 0.47
GUSB P08236 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10781901 1.00 CA12 (0.64) CA12CA1CA2CA7CA9
Octane SCHEMBL3326752 0.85 NAAA (0.63) CA12CA1CA2CA7CA9
SCHEMBL1037025 0.85 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL1805264 0.83 CES2 (0.50) CA12CA1CA2CA7CA9
SCHEMBL5369877 0.81 CES2 (0.67) CA12CA1CA2CA7CA9
SCHEMBL1329143 0.81 CES2 (0.67) CA12CA1CA2CA7CA9
SCHEMBL3905124 0.80 CA12 (0.70) CA12CA1CA2CA7CA9
SCHEMBL562543 0.79 IKBKB (0.55) CA12CA1CA2CA7CA9
SCHEMBL11337357 0.79 LCK (0.55) CA12CA1CA2CA7CA9
SCHEMBL894682 0.79 KDM4E (0.69) CA1CA2ALOX5PTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981553-B1 ADHESIVE FOR MEDICAL APPLICATIONS AND MEANS FOR HAEMOSTASIS STRYKER EUROPEAN HOLDINGS I LLC (US) 2017-03-22 EP claimed
CN-101384284-B Adhesive for medical applications and means for haemostasis STRYKER TRAUMA GMBH 2013-09-04 CN claimed
EP-2257523-B1 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES CATALYS SAS (FR) 2011-08-10 EP claimed
US-7923003-B2 Adhesive for medical applications and means for haemostasis STRYKER TRAUMA GMBH (DE) 2011-04-12 US claimed
EP-2257523-A2 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES. Catalys Sas (FR) 2010-12-08 EP claimed
WO-2009115707-A2 PREPARATION OF HYDROQUINONE AMIDE COMPOUNDS WITH ANTIOXIDANT PROPERTIES. CATALYS SAS (FR) 2009-09-24 WO claimed
US-5843618-A Hydrogen bond donating/accepting thermal solvents for image separation systems EASTMAN KODAK COMPANY (US) 1998-12-01 US claimed
US-4894409-A BLEND OR AMINO GROUP CONTAINING DIENE POLYMER AND SILICA FILLER NONCRACKING, WEAR RESISTANCE JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1990-01-16 US claimed
EP-0203468-B1 IMPROVED PHOTOGRAPHIC MATERIAL FOR TANNING DEVELOPMENT AND METHOD FOR OBTAINING A RELIEF IMAGE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-03-08 EP claimed
US-4737441-A INCLUDING TWO DIFFERENT SUBSTITUTED 1,4-DIHYDRONBENZENES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-04-12 US claimed
EP-0203468-A2 Improved photographic material for tanning development and method for obtaining a relief image MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1986-12-03 EP claimed
JP-8291044-A None JP disclosed
US-20260071103-A1 Anionic Curable Compositions DESIGNER MOLECULES INC (US) 2026-03-12 US disclosed
US-20260071104-A1 Anionic Curable Compositions DESIGNER MOLECULES INC (US) 2026-03-12 US disclosed
WO-2025021943-A1 QUINAZOLINONE, BENZOXAZINONE AND BENZOXAZEPINONE DERIVATIVES AS PROTEIN KINASE INHIBITORS NEURALIS (BE) 2025-01-30 WO disclosed
EP-0015505-A1 3-Amino-1,2-propane diols, process for their preparation, pharmaceutical compositions containing them and use thereof CIBA-GEIGY AG (CH) 1980-09-17 EP disclosed
EP-0005848-A1 N-Alkylated aminoalcohols and their salts, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1979-12-12 EP disclosed
US-4108850-A Positive-working immobile photographic azo compounds EASTMAN KODAK COMPANY (US) 1978-08-22 US disclosed
US-3980479-A Positive-working immobile photographic compounds which cleave by intramolecular nucleophilic displacement in alkali unless oxidized EASTMAN KODAK COMPANY (US) 1976-09-14 US disclosed
US-3963497-A X-ray film with hydrophillic layer containing developing and fixing agents KOSTI CARL M 1976-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071104-A1 Anionic Curable Compositions VCL, ITGA8, GABRE CA12 1927/4885CA1 1290/4885CA2 2415/4885
US-20260071103-A1 Anionic Curable Compositions CDH1, ESD, SETD2 CA12 865/4885CA1 1014/4885CA2 2476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.